首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1741413

全球个人化基因组学市场按测试类型、技术、应用、最终用户和地区划分

Personalized Genomics Market, By Test Type, By Technology, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球个人化基因组学市场规模估计为 125.5 亿美元，预计到 2032 年将达到 381.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 17.2%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	125.5亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	17.20%	2032年价值预测	381.2亿美元

个人化基因组学是一个快速发展的领域，它结合了遗传学、基因组学和个人化医疗，为了解个人基因组成提供有价值的见解。

市场动态：

全球个人化基因组学市场受多种因素驱动。首先，慢性病发病率的上升和个人化治疗的需求推动了对基因检测服务的需求。个人化基因组学有助于识别患有某些疾病的高风险个体，从而实现早期疗育和针对性治疗。例如，根据2020年9月发表在《预防慢性病》杂誌上的一篇论文，2018年，51.8%的一般民众非住院成年人被诊断出患有至少一种特定慢性病。更具体地说，24.6%的成年人患有一种慢性病，27.2%的成年人患有两种或两种以上的慢性病。

此外，次世代定序和生物资讯学等技术进步使得基因检测变得更加容易和便宜，从而扩大了提供个人化基因组服务的公司消费群。

然而，市场中也存在一些限制因素。由于基因资讯高度敏感，如果保护不当，可能会被滥用，因此人们对隐私和资料安全提出了担忧。监管挑战以及对基因数据使用和解读的明确指导方针的需求，也对市场成长构成了挑战。

儘管面临诸多挑战，个人化基因体学市场仍蕴藏着巨大的机会。人工智慧和机器学习演算法与基因分析的整合，可以提高个人化基因组学服务的准确性和效率。此外，直接面向消费者的基因检测的扩展以及医疗环境中基因检测的日益普及，为该市场的公司带来了光明的成长前景。

本研究的主要特点

本报告对全球个人化基因组学市场进行了详细分析，并以 2024 年为基准年，展示了预测期 2025 年至 2032 年的市场规模和復合年增长率。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数，介绍了全球个人化基因组学市场的主要企业概况。
本报告的见解可以帮助负责人和企业经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
可以透过用于分析全球个人化基因组学市场的各种策略矩阵来促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 12.55 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	17.20%	2032 Value Projection:	USD 38.12 Bn

The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.

Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.

However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.

Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.

Key features of the study:

This report provides in-depth analysis of the global personalized genomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Personalized Genomics; 23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Genetics, Inc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratories, Inc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized genomics market

Personalized Genomics Market Detailed Segmentation:

By Test Type
- Oncology Testing
- Infectious Disease Testing
- Neurological Testing
- Cardiovascular Testing
- Others
By Technology
- PCR-based Tests
- Microarray-based Tests
- Sequencing-based Tests
- Others
By Application
- Diagnostics
- Precision Medicine
- Wellness
- Reproductive Health
- Sports Nutrition & Health
- Lifestyle
- Others
By End User
- Hospitals & Clinics
- Research Centers
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- 23andMe
- Mapmygenome
- Invitea
- Genetic Technology Limited
- Lonza
- Interleukin Genetics, Inc
- GNA Genotek
- Helix
- MyHeritage
- Pathway Genomics
- Veritas Genetics
- Xcode
- Color Genomics
- Myriad Genetics
- Quest Diagnostics
- Bio-Rad Laboratories, Inc.
- Illumina
- Thermo Fisher Scientific
- Qiagen
- Genomic Health
- Nebula Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Genomics, By Test Type
- Market Personalized Genomics, By Technology
- Market Personalized Genomics, By Application
- Market Personalized Genomics, By End User
- Market Personalized Genomics, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing demand for personalized medicine and increase in R&D investments
- High costs and complex data interpretation
- Leveraging Big Data and Artificial Intelligence
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Personalized Genomics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Personalized Genomics Market, By Test Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Oncology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Neurological Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cardiovascular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Personalized Genomics Market, By Technology, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
PCR-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Microarray-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Sequencing-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

7. Global Personalized Genomics Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Wellness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Sports Nutrition & Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Lifestyle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Global Personalized Genomics Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

9. Global Personalized Genomics Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - South Africa
  - North Africa
  - Central Africa
  - Rest of Middle East

10. Competitive Landscape

23andMe
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mapmygenome
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invitea
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genetic Technology Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Interleukin Genetics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GNA Genotek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Helix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MyHeritage
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pathway Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Veritas Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Xcode
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Color Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Qiagen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genomic Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nebula Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球个人化基因组学市场按测试类型、技术、应用、最终用户和地区划分